RU2012111424A - Средства и способы производства искусственных капсульных полисахаридов neisseria meningitidis - Google Patents

Средства и способы производства искусственных капсульных полисахаридов neisseria meningitidis Download PDF

Info

Publication number
RU2012111424A
RU2012111424A RU2012111424/10A RU2012111424A RU2012111424A RU 2012111424 A RU2012111424 A RU 2012111424A RU 2012111424/10 A RU2012111424/10 A RU 2012111424/10A RU 2012111424 A RU2012111424 A RU 2012111424A RU 2012111424 A RU2012111424 A RU 2012111424A
Authority
RU
Russia
Prior art keywords
nucleic acid
acid molecule
capsular
carbohydrate
seq
Prior art date
Application number
RU2012111424/10A
Other languages
English (en)
Russian (ru)
Inventor
Рита ГЕРАРДИШАН
Мартина МЮЛЕНХОФФ
Андреа БЕТЕ
Катарина ШТУММЕЙЕР
Фридрих ФРАЙБЕРГЕР
Забастиан ДИМЕРОВ
Original Assignee
Медицинише Хохшуле Ханновер
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Медицинише Хохшуле Ханновер filed Critical Медицинише Хохшуле Ханновер
Publication of RU2012111424A publication Critical patent/RU2012111424A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
RU2012111424/10A 2009-08-26 2010-08-26 Средства и способы производства искусственных капсульных полисахаридов neisseria meningitidis RU2012111424A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09168765 2009-08-26
EP09168765.7 2009-08-26
PCT/EP2010/062481 WO2011023764A1 (en) 2009-08-26 2010-08-26 Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis

Publications (1)

Publication Number Publication Date
RU2012111424A true RU2012111424A (ru) 2013-10-10

Family

ID=43086450

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012111424/10A RU2012111424A (ru) 2009-08-26 2010-08-26 Средства и способы производства искусственных капсульных полисахаридов neisseria meningitidis

Country Status (8)

Country Link
US (1) US20130012471A1 (cg-RX-API-DMAC7.html)
EP (1) EP2470203A1 (cg-RX-API-DMAC7.html)
CN (1) CN102596241A (cg-RX-API-DMAC7.html)
BR (1) BR112012007877A2 (cg-RX-API-DMAC7.html)
CA (1) CA2771672A1 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN01695A (cg-RX-API-DMAC7.html)
RU (1) RU2012111424A (cg-RX-API-DMAC7.html)
WO (1) WO2011023764A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2852414B9 (en) * 2012-05-22 2020-12-09 GlaxoSmithKline Biologicals SA Meningococcus serogroup x conjugate
US10407703B2 (en) * 2014-04-17 2019-09-10 Medizinische Hochschule Hannover Means and methods for producing Neisseria meningitidis capsular polysaccharides of low dispersity
AR104469A1 (es) * 2014-08-08 2017-07-26 Glycovaxyn Ag Células huésped modificadas para su uso en producción de bioconjugados
CN107001450A (zh) * 2014-11-18 2017-08-01 巴斯德研究所 特异于脑膜炎奈瑟球菌的血清群x的多克隆抗体及其在诊断中的用途
EP3316904A1 (en) * 2015-07-01 2018-05-09 GlaxoSmithKline Biologicals S.A. Immunogenic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5792608A (en) 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
CN1401774A (zh) * 2002-07-19 2003-03-12 大连理工大学 一种尿苷二磷酸葡萄糖焦磷酸化酶基因及其克隆

Also Published As

Publication number Publication date
CN102596241A (zh) 2012-07-18
EP2470203A1 (en) 2012-07-04
BR112012007877A2 (pt) 2019-09-24
IN2012DN01695A (cg-RX-API-DMAC7.html) 2015-06-05
WO2011023764A1 (en) 2011-03-03
CA2771672A1 (en) 2011-03-03
US20130012471A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
Saxena et al. Multidomain architecture of beta-glycosyl transferases: implications for mechanism of action
DeAngelis Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, and algal viruses
US9938549B2 (en) Process for producing monosaccharides
Mühlenhoff et al. Polysialic acid: three-dimensional structure, biosynthesis and function
DeAngelis et al. Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F
Hay et al. Bacterial biosynthesis of alginates
Wang et al. The O-antigen gene cluster of Escherichia coli O55: H7 and identification of a new UDP-GlcNAc C4 epimerase gene
CN1322121C (zh) 透明质酸合酶基因及其应用
Coste et al. Production of sulfated oligosaccharides from the seaweed Ulva sp. using a new ulvan-degrading enzymatic bacterial crude extract
Chavaroche et al. Production methods for heparosan, a precursor of heparin and heparan sulfate
JP2002530087A (ja) オリゴ糖の安価な産生
PT1991690E (pt) Método para a produção de oligossacáridos sialilados
EP1392843B1 (en) Heparin/heparosan synthase and methods of making and using same
CN103228781B (zh) 软骨素的生物技术制备
CZ20003576A3 (cs) Nukleová kyselina kódující pro hyaluronan syntázu a způsoby jejího použití
Ferrero et al. Biosynthesis and production of polysialic acids in bacteria
Yates et al. Bacterial glycoengineering as a biosynthetic route to customized glycomolecules
JP2022541911A5 (cg-RX-API-DMAC7.html)
CN102596241A (zh) 生产脑膜炎奈瑟氏菌的人工荚膜多糖的方式和方法
Itano et al. Hyaluronan Synthase New Directions for Hyaluronan Research
Mathews Polyanionic proteoglycans
US10273517B2 (en) Methods of producing testosteronan polymers using testosteronan synthase
EP3131576A2 (en) Means and methods for producing neisseria meningitidis capsular polysaccharides of low dispersity
CN110643586B (zh) 一种肝素骨架合酶及其编码基因与应用
Arioli et al. Plant Cell Biology Group Research School of Biological Sciences Australian National University

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150320